Immunodeficiency in children starting antiretroviral therapy in low-, middle- and high-income countries

BACKGROUND: The CD4 cell count or percent (CD4%) at the start of combination antiretroviral therapy (cART) are important prognostic factors in children starting therapy and an important indicator of program performance. We describe trends and determinants of CD4 measures at cART initiation in childr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Acquir Immune Defic Syndr
Main Authors: Koller, Manuel, Patel, Kunjal, Chi, Benjamin H., Wools-Kaloustian, Kara, Dicko, Fatoumata, Chokephaibulkit, Kulkanya, Chimbetete, Cleophas, Avila, Dorita, Hazra, Rohan, Ayaya, Samual, Leroy, Valeriane, Trong, Huu Khanh, Egger, Matthias, Davies, Mary-Ann
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351302/
https://ncbi.nlm.nih.gov/pubmed/25501345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000380
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados